The role of proteomics in investigating psychiatric disorders

British Journal of Psychiatry

Volumn 187, Issue JULY, 2005, Pages 4-6

  Pennington, K ^a,b,c   Cotter, D ^a   Dunn, M J ^b  

^a BEAUMONT HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME;

GEL ELECTROPHORESIS; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; MENTAL DISEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REVIEW;

BRAIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MENTAL DISORDERS; PROTEOMICS;

EID: 22344441685     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.187.1.4     Document Type: Review

References (15)

1. Cannon, M., Kendell, R., Susser, E. S., et al (2003) Pre and perinatal risk factors for schizophrenia. In Epidemiology of Schizophrenia (eds R. M. Murray, P. B. Jones, E. S. Susser, et al), pp. 74-79. Cambridge: Cambridge University Press.
2. Check, E. (2004) Proteomics and cancer: running before we can walk? Nature, 429, 496-497.
3. Cutler, P. (2003) Protein arrays: the current state-of-the-art. Proteomics, 3, 3-18.
4. Edgar, P. F., Schonberger, S. J., Dean, B., et al (1999) A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Molecular Psychiatry, 4, 173-178.
5. Johnson, G., Brane, D., van Kammen, D. P., et al (1992) Haloperidol induced CSF protein variations in schizophrenic patients: as studied by two-dimensional electrophoresis. Applied and Theoretical Electrophoresis, 3, 21-26.
6. Johnson, M. D., Yu, L. R., Conrads, T. P., et al (2004) Proteome analysis of DNA damage-induced neuronal death using high throughput mass spectrometry. Journal of Biological Chemistry, 279, 26685-26697.
7. Johnston-Wilson, N. L., Sims, C. D., Hofmann, J-P., et al (2000) Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Molecular Psychiatry, 5, 142-149.
8. O'Farrell, P. H. (1975) High resolution two-dimensional electrophoresis of proteins. Journal of Biological Chemistry, 250, 4007-4021.
9. Pennington, K., Beasley, C. B., Dunn, M., et al (2004) Proteome analysis of the anterior cingulate cortex in major psychiatric disorders. Biological Psychiatry, 55, 132-133.
10. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., et al (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359, 572-577.
11. Prabakaran, S., Swatton, J. E., Ryan, M. M., et al (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular Psychiatry, 9, 684-697.
12. Shekouh, A. R., Thompson, C. C., Prime, W., et al (2003) Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics, 3, 1988-2001.
13. Thompson, P. M., Vidal, C., Giedd, J. N., et al (2001) Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proceedings of the National Academy of Sciences of the USA, 98, 11650-11655.
14. Wasinger, V. C., Cordwell, S. J., Cerpa-Poljak, A., et al (1995) Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis, 16, 1090-1094.
15. Weinberger, D. R., Egan, M. F., Bertolino, A., et al (2001) Prefrontal neurons and the genetics of schizophrenia. Biological Psychiatry, 50, 825-844.